MAPT and Alzheimer disease: Examples for biomarkers are cerebrospinal fluid biomarkers such as total tau, phosphorylated tau, and β-amyloid1–42 [1], or genetical biomarkers such as the APOE-ε4 allele as one of the strongest non-Mendelian genetic risk factors [2] for AD.